| Title : Efficacy and safety of cetagliptin as monotherapy in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial - Ji_2023_Diabetes.Obes.Metab_25_3671 |
| Author(s) : Ji L , Lu J , Gao L , Ying C , Sun J , Han J , Zhao W , Gao Y , Wang K , Zheng X , Xie D , Ding J , Zhao J , Yu Q , Wang T |
| Ref : Diabetes Obes Metab , 25 :3671 , 2023 |
| Abstract : Ji_2023_Diabetes.Obes.Metab_25_3671 |
| ESTHER : Ji_2023_Diabetes.Obes.Metab_25_3671 |
| PubMedSearch : Ji_2023_Diabetes.Obes.Metab_25_3671 |
| PubMedID: 37661308 |
Ji L, Lu J, Gao L, Ying C, Sun J, Han J, Zhao W, Gao Y, Wang K, Zheng X, Xie D, Ding J, Zhao J, Yu Q, Wang T (2023)
Efficacy and safety of cetagliptin as monotherapy in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial
Diabetes Obes Metab
25 :3671
Ji L, Lu J, Gao L, Ying C, Sun J, Han J, Zhao W, Gao Y, Wang K, Zheng X, Xie D, Ding J, Zhao J, Yu Q, Wang T (2023)
Diabetes Obes Metab
25 :3671